体重指数增加和静脉直径与功能不全大隐静脉微泡沫消融术后靶静脉不完全闭合相关
该回顾性研究分析了2018年6月至2022年9月接受1%聚多卡醇微泡沫消融术的127条肢体,发现体重指数≥30 kg/m2和静脉直径≥10.2 mm与术后静脉未闭合独立相关,未闭合组症状改善较差且静脉临床严重程度评分降低幅度较小。
要点
- 体重指数≥30 kg/m2和静脉直径增大与微泡沫消融术后静脉未闭合风险增加相关。
- 静脉直径≥10.2 mm与主干静脉未闭合独立相关,比值比为4.8。
- 未闭合与症状改善较少和术后静脉临床严重程度评分降低幅度较小相关。
核心结论
- 微泡沫消融术治疗有症状的反流性主干静脉可获得良好的总体闭合率和症状缓解。
- 体重指数≥30 kg/m2和静脉直径增大与微泡沫消融术后大隐静脉未闭合风险增加相关。
- 未闭合与症状改善较少和术后静脉临床严重程度评分降低幅度较小相关。
- 尽管本研究中消融相关血栓延伸和深静脉血栓发生率高于热消融报道的发生率,但微泡沫消融术在术后早期双功能超声监测和选择性短期抗凝下对患者是安全的。
研究设计与样本
- 回顾性审查前瞻性维护的患者数据库,纳入2018年6月至2022年9月在本门诊手术单元连续接受商用1%聚多卡醇微泡沫消融术治疗有症状浅静脉反流的患者。
- 排除仅治疗属支静脉而未行主干静脉消融的患者。
- 将患者分为完全闭合组(I组)和未闭合组(II组),分析术前人口学特征、手术细节和术后结果。
- 将单因素分析中显著的术前变量(既往深静脉血栓、体重指数≥30 kg/m2和静脉直径)纳入多因素逻辑回归模型,主要结局为静脉未闭合。
主要发现
- 共224条肢体接受微泡沫消融术,其中103例患者的127条肢体符合纳入标准。
- 完全闭合(I组)发生在115条肢体,术后双功能超声筛查显示12条肢体未闭合(II组)。
- II组平均体重指数为36.1 ± 6.4 kg/m2,显著高于I组的28.6 ± 6.1 kg/m2(P < .001)。
- 静脉直径≥10.2 mm与主干静脉未闭合独立相关,比值比为4.8。
- 微泡沫消融术后症状改善I组为96.9%,高于II组的66.7%(P = .001);术后静脉临床严重程度评分I组为8.0 ± 3.0,低于II组的9.9 ± 4.2(P = .048)。
临床怎么用
- 作者认为,微泡沫消融术在术后早期双功能超声监测和选择性短期抗凝下对患者是安全的。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patient characteristics and risk factors for incomplete or non-closure following thermal saphenous vein ablation have been reported. However, similar findings have not been clearly described following commercially manufactured polidocanol microfoam ablation (MFA). The objective of our study is to identify predictive factors and outcomes associated with non-closure following MFA of symptomatic, refluxing saphenous veins. METHODS: A retrospective review of a prospectively maintained patient database was performed from procedures in our Ambulatory Procedure Unit. All consecutive patients who underwent MFA with commercially manufactured 1% polidocanol microfoam for symptomatic superficial vein reflux between June 2018 and September 2022 were identified. Patients treated for tributary veins only, without truncal vein ablation, were excluded. Patients were then stratified into groups: complete closure (Group I) and non-closure (Group II). Preoperative demographics, procedural details, and postoperative outcomes were analyzed. Preoperative variables that were significant on univariate analysis (prior deep venous thrombosis [DVT], body mass index [BMI] ≥30 kg/m2, and vein diameter) were entered into a multivariate logistic regression model with the primary outcome being vein non-closure. RESULTS: Between June 2018 and September 2022, a total of 224 limbs underwent MFA in our ambulatory venous center. Of these, 127 limbs in 103 patients met study inclusion criteria. Truncal veins treated included the above-knee great saphenous vein (Group I: n = 89, 77% vs Group II: n = 7, 58%; P = .14), below-knee great saphenous vein (Group I: n = 7, 6% vs Group II: n = 0; P = .38), anterior accessory saphenous vein (Group I: n = 17, 15% vs Group II: n = 4, 33%; P = .12, and small saphenous vein (Group I: n = 4, 4% vs Group II: n = 1, 8%; P = .41). Complete closure (Group I) occurred in 115 limbs, and 12 limbs did not close (Group II) based on postoperative duplex ultrasound screening. The mean BMI in Group II (36.1 ± 6.4 kg/m2) was significantly greater than Group I (28.6 ± 6.1 kg/m2) (P < .001). Vein diameter of ≥10.2 mm was independently associated with truncal vein non-closure with an odds ratio of 4.8. The overall mean foam volume was 6.2 ± 2.7 ml and not different between the two cohorts (Group I: 6.2 ± 2.6 ml vs Group II: 6.3 + 3.5 ml; P = .89). Post MFA improvement in symptoms was higher in Group I (96.9%) compared with Group II (66.7%) (P = .001). The mean postoperative Venous Clinical Severity Score was also lower in Group I (8.0 ± 3.0) compared with Group II (9.9 ± 4.2) (P = .048). The overall incidences of ablation-related thrombus extension and DVT were 4.7% (n = 6) and 1.6% (n = 2), and all occurred in Group I. All were asymptomatic and resolved with anticoagulation. CONCLUSIONS: Microfoam ablation of symptomatic, refluxing truncal veins results in excellent overall closure rates and symptomatic relief. BMI ≥30 kg/m2 and increased vein diameter are associated with an increased risk of saphenous vein non-closure following MFA. Non-closure is associated with less symptomatic improvement and a lower post-procedure reduction in Venous Clinical Severity Score. Despite the incidence of ablation-related thrombus extension and DVT in this study being higher than reported rates following thermal ablation, MFA is safe for patients with early postoperative duplex ultrasound surveillance and selective short-term anticoagulation.
引用
- Talutis SD, Chin AL, Lawrence PF, et al. Increased body mass index and vein diameter are associated with incomplete target vein closure following microfoam ablation of incompetent saphenous veins. J Vasc Surg Venous Lymphat Disord. 2023. PMID: 37788744. doi:10.1016/j.jvsv.2023.09.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。